Skip to main content

Volume 15 Supplement 3

Sepsis 2011

Etiological agents of bacterial sepsis in a newly constructed medical center in Saint Petersburg, Russia


Sepsis is one of the factors of high mortality in ICUs in critically ill patients. Annual mortality from this condition is estimated at 30 to 50 deaths per 100,000 population [1, 2, 4, 5]. The aim of the present study was to reveal the spectrum and resistance to antibiotics of microorganisms, causing sepsis in hospitalized patients of the multidisciplinary medical center, that accumulates patients from all regions of Russia, during the first year from its foundation, with low possibility of local nosocomial strains formation.


The diagnosis of sepsis was verified by isolation of bacteria from blood (only two or more positive results were considered) and the presence of two or more criteria of systemic inflammatory response syndrome [3]. The cultures were isolated from blood with BactAlert (BioMerieux, France). The identification was performed by routine phenotypic methods and sequencing of the 16sRNA gene (ABI Prism 3130, MicroSeq ID v2.0 Software, MicroSeq ID 16s rDNA500 Library v2.0). Resistance to routinely used antibiotics was investigated with the disc diffusion method and by dilution techniques for MIC determination on Muller-Hinton agar (Oxoid, UK).


Sepsis, associated with bloodstream infections, was revealed in 89 cases - Gram-positive cocci predominated. Staphylococcus spp. were responsible for 35 (39.3%) cases: Staphylococcus aureus was the causative agent in eight (8.9%), coagulase-negative staphylococci (Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylo-coccus hominis novobiosepticus) in 27 (30.3%) infections. Other Gram-positive cocci were Enterococcus faecalis in eight (8.9%), Enterococcus faecium in six (6.7%). Gram-negative microorganisms included Acineto-bacter baumannii that was found in 11 (12.4%), Klebsiella spp. (Klebsiella pneumonia, Klebsiella rhinoscleromatis, Klebsiella oxytoca) in five (5.6%), Escherichia coli in eight (8.9%), Enterobacter spp. (Enterobacter cloaceae, Enterobacter aerogenes, Enterobacter hormaechea) in three (3.4%), Pseudomonas aeruginosa in two (2.2%) patients with sepsis. Rarely isolated bacteria were Bacillus thuringiensis in one (1.1%), Stenotrophomonas maltophylia in one (1.1%), Pantoeae agglomerans in one (1.1%), Corynebacterium mucifaciensis in one (1.1%) case. Two and more species were isolated from blood in seven (7.9%) patients. In total, 105 strains were isolated in sepsis cases. Resistance to antibiotics was observed in 96 (91.4%) bacterial isolates; 56 (53.3%) were multidrug-resistant strains. All E. faecium, and nine (81.8%) strains of A. baumannii were resistant to seven or more antibiotics. All E. faecium strains were susceptible to linezolide, A. baumannii to tigecycline. Methicillin resistance was detected in two (15.4%) strains of S. aureus and 18 (60.0%) strains of coagulase-negative staphylococci; four (66.7%) strains of E. faecium were vancomycin resistant.


Gram-positive bacteria were the leading causative agents of sepsis, associated with bloodstream infections in the newly-constructed hospital in Saint Petersburg. The majority of strains (91.4%) were resistant to antibiotics, and more than half of the isolates were multidrug resistant. Methicillin resistance was observed predominantly in coagulase-negative staphylococci, vancomycin resistance in E. faecium. All polyresistant E. faecium strains were susceptible to linezolide, A. baumannii to tigecycline.


  1. Carvalho PR, Trotta Ede A: Advances in sepsis diagnosis and treatment. J Pediatr (Rio J). 2003, 79 (Suppl 2): S195-S204.

    Article  Google Scholar 

  2. Braun L, Riedel AA, Cooper LM: Severe sepsis in managed care: analysis of incidence, one-year mortality, and associated costs of care. J Manag Care Pharm. 2004, 10: 521-530.

    PubMed  Google Scholar 

  3. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: ACCP/SCCM consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992, 101: 1644-1655. 10.1378/chest.101.6.1644.

    Article  CAS  PubMed  Google Scholar 

  4. Dellinger RP, Carlet JM, Masur H, Gerlac H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marchall JC, Parker MM, et al: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004, 32: 858-873. 10.1097/01.CCM.0000117317.18092.E4.

    Article  PubMed  Google Scholar 

  5. Lever A, Mackenzie I: Sepsis: definition, epidemiology, and diagnosis. BMJ. 2007, 335: 879-883. 10.1136/bmj.39346.495880.AE.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Cite this article

Barantsevich, E., Barantsevich, N., Rybkova, N. et al. Etiological agents of bacterial sepsis in a newly constructed medical center in Saint Petersburg, Russia. Crit Care 15 (Suppl 3), P45 (2011).

Download citation

  • Published:

  • DOI: